The global pseudarthrosis treatment market is projected to reach US$ 1.37 billion by 2034, driven by rising research and development, advancements in biocompatible materials, and positive government reimbursement programs. North America holds the largest market share, while demand is growing rapidly in South Asia & Pacific.